iShares Neuroscience and Healthcare ETF (NYSEARCA:IBRN) Trading 7.5% Higher – Here’s Why

iShares Neuroscience and Healthcare ETF (NYSEARCA:IBRN)’s share price were up 7.5% during trading on Wednesday . The company traded as high as $19.83 and last traded at $19.83. Approximately 4,042 shares traded hands during mid-day trading, an increase of 508% from the average daily volume of 665 shares. The stock had previously closed at $18.44.

iShares Neuroscience and Healthcare ETF Price Performance

The firm has a market cap of $2.97 million, a price-to-earnings ratio of 28.31 and a beta of 0.78. The firm has a fifty day simple moving average of $23.83 and a two-hundred day simple moving average of $25.38.

Institutional Investors Weigh In On iShares Neuroscience and Healthcare ETF

A hedge fund recently bought a new stake in iShares Neuroscience and Healthcare ETF stock. Jane Street Group LLC bought a new position in shares of iShares Neuroscience and Healthcare ETF (NYSEARCA:IBRN) in the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund bought 10,150 shares of the company’s stock, valued at approximately $254,000. Jane Street Group LLC owned 6.77% of iShares Neuroscience and Healthcare ETF as of its most recent SEC filing.

About iShares Neuroscience and Healthcare ETF

The iShares Neuroscience and Healthcare ETF (IBRN) is an exchange-traded fund that mostly invests in health care equity. The fund tracks a market cap-weighted index that provides global equity exposure to companies that are positioned to benefit from neuroscience advancements. The index may hold securities from large- to small-cap.